ArticleOncotarget2023
Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC).
Hazem I Assi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleOncotarget2023
Hazem I Assi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.